Call for Abstract

3rd International Conference on Cancer Biology & Anti-Cancer Therapies and Drug Development & Delivery , will be organized around the theme “Advancement of Cancer Biology and Eradication of Cancer

Venue: Hyatt Place Orlando Airport 5435 Forbes Place Orlando, Florida, 32812, USA”

Cancer Biology 2019 is comprised of 10 tracks and 37 sessions designed to offer comprehensive sessions that address current issues in Cancer Biology 2019.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body A benign tumor is a mass of cells that lack the ability to invade neighboring tissue or metastasize. These do not spread into, or invade nearby tissues; however, they can sometimes be quite large. When removed, usually they don't grow back. Malignant means that the tumor is made of cancer cells and it can invade nearby tissues. Some cancer cells can move into the bloodstream or lymph nodes, where they can spread to other tissues within the body-this is called metastasis. Cancer can occur anywhere in the body, including the breast, lungs, intestines, reproductive organs, blood, or skin.

  • Track 2-1Benign Tumor
  • Track 2-2Skin Cancer
  • Track 2-3Blood Cancer
  • Track 2-4Reproductive Cancer
  • Track 2-5Gastrointestinal Cancer
  • Track 2-6Lung Cancer Blood Cancer
  • Track 2-7Breast Cancer
  • Track 2-8Malignant Tumors
  • Track 2-9Necrosis
  • Track 2-10Ischemia
  • Track 2-11Angiolipoma
  • Track 2-12Lipomas
  • Track 2-13Myxoma
  • Track 2-14Neurilemmoma
  • Track 2-15Schwannoma
  • Track 2-16Neurofibroma
  • Track 2-17 Fibroids
  • Track 2-18 Adenomas
  • Track 2-19By injection

A cancer biomarker alludes to a substance or process that is demonstrative of the potency of generation of tumor in the body. A biomarker might be a particle emitted by a tumor or a particular reaction of the body in the vicinity of the disease. Hereditary, epigenetic, proteomic, glycomic and imaging biomarkers can be utilized for malignancy determination, anticipation and the study of disease transmission. In a perfect world, such biomarkers can be tested in non-obtrusive gathered bio-fluids like blood or serum.


  • Track 3-1Prognosis and treatment predictions
  • Track 3-2Monitoring treatment response

Many anti-cancer drugs and therapies are as well known for the associated side effects as their therapeutic benefit. These instantly recognizable side effects can necessitate the reduction of dosage of a drug and can have a serious effect on the well-being of patients. New cancer drug delivery systems are in development to minimize harm to non-cancerous cells, whilst enhancing the effect on the tumor itself.


  • Track 4-1Surgery for cancer
  • Track 4-2Radiotherapy
  • Track 4-3Chemotherapy
  • Track 4-4Gene Therapy
  • Track 4-5Antisense Therapy

 Different drugs come in different forms-tablets, capsules, liquids or medicines swallow. But there are drugs you cannot swallow because they irritate the stomach too much. Or because they would just pass straight through the gut without being absorbed by the body.


\r\n There are two broad types of cancer vaccines:


\r\n Therapeutic vaccines, which are intended to treat existing cancer by strengthening the body's natural defenses against cancer.


  • Track 6-1Tumor cell vaccines
  • Track 6-2Anti-Idiotype antibody-based vaccines
  • Track 6-3Dendritic cell vaccines
  • Track 6-4DNA vaccines
  • Track 6-5Viral-vector based vaccines
  • Track 6-6Antigen vaccines




<p style="\&quot;text-align:" justify;\"="">\r\n The study of epigenetic modifications to the genome of cancer cells that do not include a change in the nucleotide sequence is known as Cancer Epigenetics. Epigenetic alterations are as important as genetic mutations in a cell's transformation to cancer and their manipulation embraces the great potential for cancer prevention, detection, and therapy. A variety of compounds are considered as epigenetic carcinogens such as Usenet, diethylstilbestrol, Hexachlorobenzene and nickel compounds. They result in an increased incidence of tumors, but they do not show mutagen activity.


Clinical trials are usually conducted in a progressive series of steps, called phases. The process starts with small trials testing the safety of an intervention and moves to progressively larger trials. The larger trials compare the effectiveness of the new intervention given to the investigation group to the currently accepted standard care given to the control group. Clinical trials are mechanisms for developing better methods of prevention, screening, diagnosis and treatment work better than those currently used, and whether they are safe.


  • Track 8-1Prevention Trails
  • Track 8-2Screening Trails
  • Track 8-3Diagnostic Trails
  • Track 8-4Treatment Trails
  • Track 8-5Quality of life Trails

The genome of a cancer cell can also be used to tell one type of cancer from another. In some cases, studying the genome in cancer can help identify a subtype of cancer within that type, such as HER2+ breast cancer. Understanding the cancer genome may also help a doctor select the best treatment for each patient.


An oncology nurse is a selected mature who takes care of and shows patients who have a tumor. Oncology specialists work in a multi-disciplinary gathering, in a combination of settings, from the inpatient ward, where it counts the marrow transplant unit, through to the group. They may work with a variety of patients, from children to the elderly, from outpatients through to palliative care.